Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naïve Adults

Plasmodium falciparum apical membrane antigen 1 (AMA1) is a candidate malaria vaccine antigen expressed on merozoites and sporozoites. The polymorphic nature of AMA1 may compromise vaccine induced protection. The humoral response induced by two dosages (10 and 50 µg) of a single allele AMA1 antigen (FVO) formulated with Alhydrogel, Montanide ISA 720 or AS02 was investigated in 47 malaria-naïve adult volunteers. Volunteers were vaccinated 3 times at 4 weekly intervals and serum samples obtained four weeks after the third immunization were analysed for (i) Antibody responses to various allelic variants, (ii) Domain specificity, (iii) Avidity, (iv) IgG subclass levels, by ELISA and (v) functionality of antibody responses by Growth Inhibition Assay (GIA). About half of the antibodies induced by vaccination cross reacted with heterologous AMA1 alleles. The choice of adjuvant determined the magnitude of the antibody response, but had only a marginal influence on specificity, avidity, domain recognition or subclass responses. The highest antibody responses were observed for AMA1 formulated with AS02. The Growth Inhibition Assay activity of the antibodies was proportional to the amount of antigen specific IgG and the functional capacity of the antibodies was similar for heterologous AMA1-expressing laboratory strains. Trial Registration ClinicalTrials.gov NCT00730782

[1]  C. Wiener.  Harrison's principles of internal medicine , 2013 .

[2]  A. Thomas,et al.  Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT™ Protects against Blood-Stage Challenge in Rhesus Macaques , 2011, PloS one.

[3]  A. Thomas,et al.  Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits , 2011, Malaria Journal.

[4]  A. Folgori,et al.  Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines , 2010, The Journal of Immunology.

[5]  A. Thomas,et al.  Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response , 2010, PloS one.

[6]  A. Thomas,et al.  Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity , 2009, PloS one.

[7]  V. A. Stewart,et al.  Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A , 2009, PloS one.

[8]  A. Thomas,et al.  Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02 , 2008, PloS one.

[9]  A. Thomas,et al.  Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. , 2008, Vaccine.

[10]  M. Fay,et al.  Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria , 2008, PloS one.

[11]  R. Chilengi,et al.  Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children , 2008, Malaria Journal.

[12]  A. Thomas,et al.  A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits , 2008, Infection and Immunity.

[13]  A. Thomas,et al.  Apical membrane antigen 1: a malaria vaccine candidate in review. , 2008, Trends in parasitology.

[14]  R. Chilengi,et al.  Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa , 2007, Infection and Immunity.

[15]  A. Thomas,et al.  Malaria Vaccine-Related Benefits of a Single Protein Comprising Plasmodium falciparum Apical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1 , 2007, Infection and Immunity.

[16]  A. Batchelor,et al.  Structural basis of antigenic escape of a malaria vaccine candidate , 2007, Proceedings of the National Academy of Sciences.

[17]  A. Thomas,et al.  Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. , 2005, Molecular and biochemical parasitology.

[18]  Aditi Gupta,et al.  Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Hong Zhou,et al.  Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria , 2005, Infection and Immunity.

[20]  Alan W. Thomas,et al.  Crystal Structure of the Malaria Vaccine Candidate Apical Membrane Antigen 1 , 2005, Science.

[21]  J. K. Moch,et al.  Production of the Subdomains of the Plasmodium falciparum Apical Membrane Antigen 1 Ectodomain and Analysis of the Immune Response , 2004, Infection and Immunity.

[22]  A. Cowman,et al.  Allelic polymorphisms in apical membrane antigen‐1 are responsible for evasion of antibody‐mediated inhibition in Plasmodium falciparum , 2004, Molecular microbiology.

[23]  Markus S. Mueller,et al.  A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites* , 2004, Journal of Biological Chemistry.

[24]  A. Thomas,et al.  Apical Membrane Antigen 1, a Major Malaria Vaccine Candidate, Mediates the Close Attachment of Invasive Merozoites to Host Red Blood Cells , 2004, Infection and Immunity.

[25]  A. Thomas,et al.  Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development , 2003, Journal of Cell Science.

[26]  A. Saul,et al.  In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response , 2002, Infection and Immunity.

[27]  S. Ralph,et al.  Independent Translocation of Two Micronemal Proteins in Developing Plasmodium falciparum Merozoites , 2002, Infection and Immunity.

[28]  A. Thomas,et al.  High-Level Expression of the Malaria Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte Invasion , 2002, Infection and Immunity.

[29]  S. Howell,et al.  Proteolytic Processing and Primary Structure ofPlasmodium falciparum Apical Membrane Antigen-1* , 2001, The Journal of Biological Chemistry.

[30]  R. Anders,et al.  Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes , 1996, Infection and immunity.

[31]  J. Bigby.  Harrison's Principles of Internal Medicine , 1988 .

[32]  L. Krishnan,et al.  Introduction to the immune system. , 2013, Methods in molecular biology.

[33]  J. Stockman.  A Field Trial to Assess a Blood-Stage Malaria Vaccine , 2013 .

[34]  David Male,et al.  Introduction to the Immune System , 2006 .

[35]  L. Hammarström,et al.  IgG subclass changes in response to vaccination. , 1986, Monographs in allergy.